Abstract
Background
Bleeding from esophageal varices is a leading cause of death in alcoholic cirrhotic patients. The aim of the present single-center study was to identify risk factors predictive of variceal rebleeding and death within 6 weeks of initial treatment.
Methods
Univariate and multivariate analyses were performed on 310 prospectively documented alcoholic cirrhotic patients with acute variceal hemorrhage (AVH) who underwent 786 endoscopic variceal injection treatments between January 1984 and December 2006. All injections were administered during the first 6 weeks after the patients were treated for their first variceal bleed.
Results
Seventy-five (24.2%) patients experienced a rebleed, 38 within 5 days of the initial treatment and 37 within 6 weeks of their initial treatment. Of the 15 variables studied and included in a multivariate analysis using a logistic regression model, a bilirubin level >51 mmol/l and transfusion of >6 units of blood during the initial hospital admission were predictors of variceal rebleeding within the first 6 weeks. Seventy-seven (24.8%) patients died, 29 (9.3%) within 5 days and 48 (15.4%) between 6 and 42 days after the initial treatment. Stepwise multivariate logistic regression analysis showed that six variables were predictors of death within the first 6 weeks: encephalopathy, ascites, bilirubin level >51 mmol/l, international normalized ratio (INR) >2.3, albumin <25 g/l, and the need for balloon tube tamponade.
Conclusions
Survival was influenced by the severity of liver failure, with most deaths occurring in Child-Pugh grade C patients. Patients with AVH and encephalopathy, ascites, bilirubin levels >51 mmol/l, INR >2.3, albumin <25 g/l and who require balloon tube tamponade are at increased risk of dying within the first 6 weeks. Bilirubin levels >51 mmol/l and transfusion of >6 units of blood were predictors of variceal rebleeding.
Similar content being viewed by others
References
Krige JEJ, Shaw JM, Bornman PC (2005) The evolving role of endoscopic treatment for bleeding esophageal varices. World J Surg 29:966–973
Krige JEJ, Beningfield SJ, Shaw J (2007) Management of bleeding oesophageal varices. In: Johnson C, Taylor I (eds) Recent advances in surgery, 30th edn. Royal Society of Medicine, London, pp 105–125
Sharara AI, Rockey DC (2001) Gastroesophageal variceal hemorrhage. N Engl J Med 345:669–681
Triantos CK, Goulis J, Patch D et al (2006) An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy 38:797–807
Chalasani N, Kahi C, Francois F et al (2003) Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 98:653–659
Carbonell N, Pauwels A, Serfaty L et al (2004) Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40:652–659
Mihas AA, Sanyal AJ (2004) Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology 127:621–629
Henderson JM, Barnes DS, Geisinger MA (1998) Portal hypertension. Curr Probl Surg 35:379–452
Christensen E (1997) Prognostic models in chronic liver disease: validity, usefulness and future role. J Hepatol 26:1414–1424
Terblanche J, Bornman PC, Kahn D (1983) Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding: a five-year prospective controlled clinical trial. Lancet 2:1328–1332
Terblanche J, Kahn D, Bornman PC (1989) Long-term injection sclerotherapy treatment for esophageal varices: a 10 year prospective evaluation. Ann Surg 210:725–731
Bornman PC, Kahn D, Terblanche J et al (1988) Rigid versus fiberoptic endoscopic injection sclerotherapy. A prospective randomized controlled trial in patients with bleeding esophageal varices. Ann Surg 208:175–178
Kahn D, Krige JE, Terblanche J et al (1994) A 15-year experience of injection sclerotherapy in adult patients with extrahepatic portal venous obstruction. Ann Surg 219:34–39
Krige JE, Bornman PC, Goldberg PA et al (2000) Variceal rebleeding and recurrence after endoscopic injection sclerotherapy: a prospective evaluation in 204 patients. Arch Surg 135:1315–1322
Krige JEJ, Kotze UK, Bornman PC et al (2006) Recurrence, rebleeding and survival after endoscopic injection sclerotherapy in alcoholic patients with bleeding esophageal varices. Ann Surg 244:764–770
Krige JEJ, Terblanche J (1996) Injection sclerotherapy of oesophageal varices. In: Carter D, Russell RCG, Pitt H, Bismuth H (eds) Rob and Smith’s operative surgery. Surgery of the liver, pancreas and bile ducts, 5th edn. Chapman and Hall Medical, London, pp 163–172
Krige JEJ, Bornman PC (2007) Endoscopic therapy in the management of esophageal varices: injection sclerotherapy and variceal ligation. In: Blumgart L (ed) Surgery of the liver, biliary tract and pancreas, 4th edn. Saunders Elsevier, Philadelphia, pp 1579–1593
Krige JEJ, Bornman PC (2006) Endoscopic therapy in the management of esophageal varices: injection sclerotherapy and variceal ligation. In: Fischer JE (ed) Mastery of surgery, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1367–1378
Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649
D’Amico G, De Franchis R, Cooperative Study Group (2003) Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38:599–612
Thomopoulos K, Theocharis G, Mimidis K et al (2006) Improved survival of patients presenting with acute variceal bleeding. Prognostic indicators of short- and long-term mortality. Dig Liver Dis 38:899–904
Boix J, Lorenzo-Zúñiga V, Moreno de Vega V et al (2007) Sclerotherapy and esophageal variceal bleeding: time to forget it, or not? Endoscopy 39:478
Ben-Ari Z, Cardin F, McCormick AP et al (1999) A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol 31:443–450
Siringo S, McCormick PA, Mistry P et al (1991) Prognostic significance of the white nipple sign in variceal bleeding. Gastrointest Endosc 37:51–55
Zhao C, Chen SB, Zhou JP et al (2002) Prognosis of hepatic cirrhosis patients with esophageal or gastric variceal hemorrhage: multivariate analysis. Hepato-Biliary Pancreat Dis Int 1:416–419
Jalan R, Hayes PC (2000) UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 46(Suppl 3–4):III1–III15
Poynard T, Lebrec D, Hillon P et al (1987) Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleeding. Hepatology 7:447–451
Sanders DS, Carter MJ, Goodchap RJ et al (2002) Prospective validation of the Rockall risk scoring system for upper GI hemorrhage in subgroups of patients with varices and peptic ulcers. Am J Gastroenterol 97:630–635
Bosch J, Berzigotti A, Garcia-Pagan JC et al (2008) The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 48(Suppl 1):S68–S92
Bhasin DK, Siyad I (2004) Variceal bleeding and portal hypertension: new lights on old horizon. Endoscopy 36:120–129
Goulis J, Armonis A, Patch D et al (1998) Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 27:1207–1212
Bernard B, Grangé JD, Khac EN et al (1999) Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29:1655–1661
Avgerinos A, Armonis A, Stefanidis G et al (2004) Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology 39:1623–1630
Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L et al (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40:793–801
Moitinho E, Escorsell A, Bandi JC et al (1999) Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117:626–631
de Franchis R (2005) Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43:167–176
Bosch J, Abraldes JG, Groszmann R (2003) Current management of portal hypertension. Hepatology 38:S54–S68
Le Moine O, Adler M, Bourgeois N et al (1992) Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy. Gut 33:1381–1385
Graham DY, Smith JL (1981) The course of patients after variceal hemorrhage. Gastroenterology 80:800–809
Graffeo M, Buffoli F, Lanzani G et al (1994) Survival after endoscopic sclerotherapy for esophageal varices in cirrhotics. Am J Gastroenterol 89:1815–1822
Prindiville T, Miller M, Trudeau W (1987) Prognostic indicators in acute variceal hemorrhage after treatment by sclerotherapy. Am J Gastroenterol 82:655–659
Yang MT, Chen HS, Lee HC et al (2007) Risk factors and survival of early bleeding after esophageal variceal ligation. Hepatogastroenterology 54:1705–1709
Amitrano L, Guardascione MA, Bennato R et al (2005) MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol 42:820–825
Cárdenas A, Ginès P, Uriz J et al (2001) Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 34:671–676
Garden OJ, Motyl H, Gilmour WH et al (1985) Prediction of outcome following acute variceal haemorrhage. Br J Surg 72:91–95
Lata J, Husová L, Juránková J et al (2006) Factors participating in the development and mortality of variceal bleeding in portal hypertension—possible effects of the kidney damage and malnutrition. Hepatogastroenterology 53:420–425
Gatta A, Merkel C, Amodio P et al (1994) Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: a multicenter study. Am J Gastroenterol 89:1528–1536
Hori S, Takaki A, Okada H et al (2006) Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients. J Gastroenterol Hepatol 21:1704–1709
Srikureja W, Kyulo NL, Runyon BA et al (2005) MELD score is a better prognostic model than Child-Turcotte-Pugh score or discriminant function score in patients with alcoholic hepatitis. J Hepatol 42:700–706
Lo GH, Chen WC, Chen MH et al (2004) The characteristics and the prognosis for patients presenting with actively bleeding esophageal varices at endoscopy. Gastrointest Endosc 60:714–720
D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217–231
Garcia-Tsao G, Bosch J, Groszmann RJ (2008) Portal hypertension and variceal bleeding—unresolved issues. Summary of an American Association for the Study of Liver Diseases and European Association for the Study of the Liver single-topic conference. Hepatology 47:1764–1772
Atkinson RJ, Hurlstone DP (2008) Usefulness of prognostic indices in upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 22:233–242
Angermayr B, Cejna M, Karnel F et al (2003) Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 52:879–885
Cholongitas E, Papatheodoridis GV, Vangeli M et al (2005) Systematic review: the model for end-stage liver disease–should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 22:1079–1089
Bambha K, Kim WR, Pedersen R et al (2008) Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut 57:814–820
Huo TI, Lee SD, Lin HC (2008) Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int 28:606–613
Thalheimer U, Triantos CK, Samonakis DN et al (2005) Infection, coagulation, and variceal bleeding in cirrhosis. Gut 54:556–563
Thabut D, Bernard-Chaber TB (2007) Management of acute bleeding from portal hypertension. Best Pract Res Clin Gastroenterol 21:19–29
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krige, J.E.J., Kotze, U.K., Distiller, G. et al. Predictive Factors for Rebleeding and Death in Alcoholic Cirrhotic Patients with Acute Variceal Bleeding: A Multivariate Analysis. World J Surg 33, 2127–2135 (2009). https://doi.org/10.1007/s00268-009-0172-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-009-0172-6